Christopher Reiners

Summary

Country: Germany

Publications

  1. ncbi request reprint [Radioiodine therapy of Graves' disease--quality assurance and radiation protection]
    C Reiners
    Klinik und Poliklinik für Nuklearmedizin Würzburg
    Z Arztl Fortbild Qualitatssich 93:61-6. 1999
  2. ncbi request reprint [Radioiodine therapy for Graves' disease: problems and new developments]
    Christoph Reiners
    Klinik und Poliklinik für Nuklearmedizin der Universität Würzburg
    Z Arztl Fortbild Qualitatssich 98:55-62. 2004
  3. doi request reprint Radio-iodine therapy in differentiated thyroid cancer: indications and procedures
    Christoph Reiners
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Best Pract Res Clin Endocrinol Metab 22:989-1007. 2008
  4. ncbi request reprint Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees
    Christoph Reiners
    Department of Nuclear Medicine, University of Wurzburg, Germany
    Thyroid 14:926-32. 2004
  5. doi request reprint [Malignant goiter--thyroid cancer]
    Chr Reiners
    Klinik und Poliklinik fur Nuklearmedizin, Universitat Wurzburg
    Dtsch Med Wochenschr 133:2215-28; quiz 2229-30. 2008
  6. ncbi request reprint Thyroid cancer in infants and adolescents after Chernobyl
    C Reiners
    Clinic and Policlinic of Nuclear Medicine, University of Wuerzburg, Wuerzburg, Germany
    Minerva Endocrinol 33:381-95. 2008
  7. ncbi request reprint Radioiodine therapy of thyroid autonomy
    Christoph Reiners
    Clinic and Policlinic for Nuclear Medicine, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 29:S471-8. 2002
  8. ncbi request reprint A perspective on post-Chernobyl radioablation in young females
    Christoph Reiners
    University of Würzburg Würzburg, Germany
    J Nucl Med 47:1563-4. 2006
  9. ncbi request reprint Differentiated thyroid cancer in childhood: pathology, diagnosis, therapy
    Christoph Reiners
    Clinic and Policlinic for Nuclear Medicine, University of Wurzburg
    Pediatr Endocrinol Rev 1:230-5; discussion 235-6. 2003
  10. ncbi request reprint Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131
    C Reiners
    Nuclear Medicine Clinic, University of Wurzburg, Germany
    J Endocrinol Invest 22:17-24. 1999

Detail Information

Publications56

  1. ncbi request reprint [Radioiodine therapy of Graves' disease--quality assurance and radiation protection]
    C Reiners
    Klinik und Poliklinik für Nuklearmedizin Würzburg
    Z Arztl Fortbild Qualitatssich 93:61-6. 1999
    ..However, patients have to be followed-up for life. Considering the cost-benefit-relation, radioiodine treatment has advantages especially in patients with small goiters as compared to surgery...
  2. ncbi request reprint [Radioiodine therapy for Graves' disease: problems and new developments]
    Christoph Reiners
    Klinik und Poliklinik für Nuklearmedizin der Universität Würzburg
    Z Arztl Fortbild Qualitatssich 98:55-62. 2004
    ..Present results suggest that the risks of radioiodine treatment in Graves' disease patients are very low, while at the same time the cost-effectiveness of this treatment regimen is high...
  3. doi request reprint Radio-iodine therapy in differentiated thyroid cancer: indications and procedures
    Christoph Reiners
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Best Pract Res Clin Endocrinol Metab 22:989-1007. 2008
    ..The standard approach to preparation for 131I therapy in patients with metastases is endogenous hypothyroidism after thyroid hormone withdrawal...
  4. ncbi request reprint Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees
    Christoph Reiners
    Department of Nuclear Medicine, University of Wurzburg, Germany
    Thyroid 14:926-32. 2004
    ..These results emphasize the importance of effective sonographic screening to detect early thyroid abnomalities in order to initiate preventive and therapeutic measures to prevent the onset or progression of disease and its sequels...
  5. doi request reprint [Malignant goiter--thyroid cancer]
    Chr Reiners
    Klinik und Poliklinik fur Nuklearmedizin, Universitat Wurzburg
    Dtsch Med Wochenschr 133:2215-28; quiz 2229-30. 2008
  6. ncbi request reprint Thyroid cancer in infants and adolescents after Chernobyl
    C Reiners
    Clinic and Policlinic of Nuclear Medicine, University of Wuerzburg, Wuerzburg, Germany
    Minerva Endocrinol 33:381-95. 2008
    ..Generally, young patients treated with high activities of radioiodine should be carefully followed up during their whole lifespan...
  7. ncbi request reprint Radioiodine therapy of thyroid autonomy
    Christoph Reiners
    Clinic and Policlinic for Nuclear Medicine, University of Wurzburg, Josef Schneider Strasse 2, 97080 Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 29:S471-8. 2002
    ..Therapy-related risks, such as immunogenic hypothyroidism or thyroid cancer, are discussed. (131)I treatment of functional autonomy and hyperthyroidism is considered an effective and safe procedure...
  8. ncbi request reprint A perspective on post-Chernobyl radioablation in young females
    Christoph Reiners
    University of Würzburg Würzburg, Germany
    J Nucl Med 47:1563-4. 2006
  9. ncbi request reprint Differentiated thyroid cancer in childhood: pathology, diagnosis, therapy
    Christoph Reiners
    Clinic and Policlinic for Nuclear Medicine, University of Wurzburg
    Pediatr Endocrinol Rev 1:230-5; discussion 235-6. 2003
    ..The treatment of children with disseminated pulmonary metastases however, may be complicated due to the increased risk of the induction of pulmonary fibrosis by radioiodine...
  10. ncbi request reprint Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131
    C Reiners
    Nuclear Medicine Clinic, University of Wurzburg, Germany
    J Endocrinol Invest 22:17-24. 1999
    ..Ongoing dosimetric research eventually may provide more specific guidance regarding radioiodine activities for diagnostic, and, particularly, therapeutic purposes, with the use of rhTSH...
  11. ncbi request reprint Radioactivity and thyroid cancer
    Christopher Reiners
    Clinic and Polyclinic of Nuclear Medicine University of Würzburg
    Hormones (Athens) 8:185-91. 2009
    ....
  12. ncbi request reprint Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995
    Jamshid Farahati
    Department of Nuclear Medicine, University of Wuerzburg, Germany
    Thyroid 14:141-7. 2004
    ..A population-based registry (PBR) in Lower Frankonia in southern Germany was conducted to evaluate the changes of incidence and prognosis of thyroid carcinoma (TC) in this area...
  13. doi request reprint Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, 97080 Wurzburg, Germany
    J Clin Endocrinol Metab 94:3948-53. 2009
    ..Although recombinant human TSH (rhTSH) is widely used in differentiated thyroid cancer (DTC) to aid diagnostic follow-up procedures and radioiodine thyroid remnant ablation, almost all clinical investigation was in adults...
  14. doi request reprint Intratracheal growth of recurrent benign goiter
    Frederik A Verburg
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    Thyroid 19:1009-11. 2009
    ..Intratracheal goiter manifestations caused by ectopic thyroid tissue have occasionally been reported. We report a 42-year-old female who had undergone thyroid surgery twice, which had caused unilateral recurrent laryngeal nerve palsy...
  15. ncbi request reprint Evaluation of an internet-based e-learning module to introduce nuclear medicine to medical students: a feasibility study
    Stefanie Diessl
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    Nucl Med Commun 31:1063-7. 2010
    ..Aim: To evaluate the additional educational value of a voluntary e-learning module in a nuclear medicine course for third-year medical students...
  16. ncbi request reprint Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal
    Heribert Hänscheid
    Klinik und Poliklinik fur Nuklearmedizin, Universitat Wurzburg, D 97080 Wurzburg, Germany
    J Nucl Med 47:648-54. 2006
    ..7 GBq (131)I in differentiated thyroid cancer after stimulation with recombinant human TSH (rhTSH) or by thyroid hormone withdrawal (THW) are presented...
  17. doi request reprint In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer
    Michael Lassmann
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    J Nucl Med 51:1318-25. 2010
    ....
  18. ncbi request reprint Thyroid cancer in childhood: management strategy, including dosimetry and long-term results
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Germany
    Hormones (Athens) 6:269-78. 2007
    ..These considerations have led to individualized "tailored" therapeutic approaches based on prior risk stratification. This article mainly deals with novel nuclear medicine concepts for dosing regimens in radioiodine therapy...
  19. doi request reprint Dosimetry and thyroid cancer: the individual dosage of radioiodine
    Michael Lassmann
    Department of Nuclear Medicine, University of Wurzburg, Oberdurrbacher Strasse 6, D 97080 Wurzburg, Germany
    Endocr Relat Cancer 17:R161-72. 2010
    ..The limitations of treatments aiming at high absorbed doses are addressed as well as the doses to normal organs. Finally, new concepts for further elaborating the potential of thyroid cancer treatment using (131)I are introduced...
  20. doi request reprint German hospital database-allocation of patients to appropriate hospitals
    Rita Schneider
    Department of Nuclear Medicine, University of Wurzburg, University Clinic, WHO REMPAN Collaborating Centre, Oberdürrbacher Str 6, D 97080 Wurzburg, Germany
    Health Phys 98:799-803. 2010
    ..In this publication baseline data of qualified hospitals concerning capacities and competence to manage radiological emergency patients are presented, and an allocation concept for radiological emergency patients is provided...
  21. doi request reprint No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
    Frederik Anton Verburg
    Department of Nuclear Medicine, University of Wurzburg, Oberdurrbacher Strasse 6, Wurzburg, 97080, Germany
    Eur J Nucl Med Mol Imaging 37:276-83. 2010
    ....
  22. doi request reprint Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
    Frederik A Verburg
    Department of Nuclear Medicine, University of Wurzburg, Oberdurrbacher Strasse 6, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 37:896-903. 2010
    ..We sought to evaluate the safety and effectiveness in everyday tertiary referral centre practice of treating advanced DTC with high (131)I activities chosen primarily based on the results of dosimetry following this SOP...
  23. doi request reprint Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma
    Frederik A Verburg
    Department of Nuclear Medicine, University Clinic Würzburg, University of Wurzburg, Wurzburg, Germany
    Clin Endocrinol (Oxf) 71:291-7. 2009
    ..To study the relationship between primary tumour size and the risk of advanced disease features (multifocal or locally invasive disease, lymph-node or distant metastases) in differentiated thyroid carcinoma (DTC)...
  24. doi request reprint Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas
    Samuel Samnick
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    J Nucl Med 50:2025-32. 2009
    ..This study tested the efficacy of (131)I-IPA combined with external beam photon radiotherapy as a new therapeutic approach against gliomas...
  25. doi request reprint Histology does not influence prognosis in differentiated thyroid carcinoma when accounting for age, tumour diameter, invasive growth and metastases
    Frederik A Verburg
    Department of Nuclear Medicine, Wurzburg University, Wurzburg, Germany
    Eur J Endocrinol 160:619-24. 2009
    ..The aim of this study was to investigate whether there are differences in tumour-specific survival if initial staging is accounted for...
  26. doi request reprint Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma
    Heribert Hänscheid
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    Endocr Relat Cancer 16:1283-9. 2009
    ....
  27. doi request reprint A comparison of prognostic classification systems for differentiated thyroid carcinoma
    Frederik A Verburg
    University of Wurzburg, Department of Nuclear Medicine, Wurzburg, Germany
    Clin Endocrinol (Oxf) 72:830-8. 2010
    ..To identify and compare prognostic classification systems based on basic tumour characteristics that were developed and/or validated for differentiated thyroid carcinoma (DTC)...
  28. ncbi request reprint Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Germany
    Thyroid 15:1147-55. 2005
    ..In conclusion, hypothyroidism secondary to withdrawal causes important morbidity, safety risks, and productivity impairment. rhTSH avoids these drawbacks at roughly equivalent societal cost to that of withdrawal...
  29. ncbi request reprint Radiosynovectomy in rheumatology, orthopedics, and hemophilia
    Peter Schneider
    Clinic for Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    J Nucl Med 46:48S-54S. 2005
    ..In addition, local instillation of radiopharmaceuticals can effectively reduce effusions after implantation of a prosthesis...
  30. ncbi request reprint Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis
    Ralf Giess
    Department of Neurology, University of Wuerzburg, Germany
    J Neurol 249:1246-9. 2002
    ..Our data show early subclinical autonomic involvement supporting the view that ALS is a multisystem degenerative disease...
  31. ncbi request reprint Therapy of ankylosing spondylitis with 224Ra-radium chloride: dosimetry and risk considerations
    Michael Lassmann
    Department of Nuclear Medicine, University of Wurzburg, 97080 Wurzburg, Germany
    Radiat Environ Biophys 41:173-8. 2002
    ..After a treatment schedule of 10 intravenous injections, each with 1 MBq of (224)Ra, the absorbed doses were calculated to be highest on the bone surface of the patient (4.4 Gy) with a resulting effective dose of 2.5 Sv...
  32. ncbi request reprint High gradient magnetic cell sorting and internal standardisation substantially improve the assay for somatic mutations at the glycophorin A (GPA) locus
    Klaus Hempel
    Klinik und Poliklinik für Nuklearmedizin der Universität, Wurzburg, Josef Schneider Str 2, D 97080 Wurzburg, Germany
    Mutat Res 525:29-42. 2003
    ..Tn positive RBC behave in MACS like variants. It is demonstrated that in normal individuals Tn cells (frequency: approximately 2 x 10(-8)) do not disturb the assay...
  33. ncbi request reprint Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 30:1371-7. 2003
    ..It is quite possible that "stunning" from the radioiodine administered in the initial uptake study inhibited the subsequent uptake of radioiodine by the remnant lesions in the second uptake study...
  34. ncbi request reprint rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Endocr Relat Cancer 12:49-64. 2005
    ....
  35. ncbi request reprint The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomy
    Peter Schneider
    Clinic for Nuclear Medicine, University of Wurzburg, Josef Schneider Strasse 2, 97080, Wurzburg, Germany
    Eur J Nucl Med Mol Imaging 32:788-93. 2005
    ..In a prospective randomised study, we investigated the influence of the route of administration of radioiodide on dosimetry and therapy outcome...
  36. ncbi request reprint Impact of 131I diagnostic activities on the biokinetics of thyroid remnants
    Michael Lassmann
    Klinik und Poliklinik für Nuklearmedizin der Universität Würzburg, Wurzburg, Germany
    J Nucl Med 45:619-25. 2004
    ..Stunning may play a major role in reducing the therapeutic efficacy of high (131)I activities given for ablation therapy...
  37. ncbi request reprint [Radiotherapy of hyperthyroidism--why, what for, when, how?]
    Christoph Reiners
    Klinik und Poliklinik fur Nuklearmedizin, Universitat Wurzburg
    Krankenpfl J 40:16-21. 2002
  38. doi request reprint [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes
    Stefanie Hahner
    Endocrinology and Diabetes Unit, Department of Medicine, University of Wuerzburg, Josef Schneider Strasse 2, Wuerzburg, Germany
    J Clin Endocrinol Metab 93:2358-65. 2008
    ..New specific imaging methods would therefore be of great clinical value. We, therefore, studied the potential of iodometomidate (IMTO) as tracer for molecular imaging of cytochrome P450 family 11B (Cyp11B) enzymes...
  39. ncbi request reprint Accuracy of three-dimensional ultrasound for thyroid volume measurement in children and adolescents
    Andrej Lyshchik
    Laboratory of Thyroidology, Clinical Research Institute for Radiation Medicine and Endocrinology, Minsk, Belarus
    Thyroid 14:113-20. 2004
    ..5%) than 2D US with 14.4% variability and 84.8% repeatability (p < 0.001). In conclusion, three-dimensional sonography allows accurate measurement of thyroid volume with low intraobserver variability and high repeatability...
  40. ncbi request reprint Dose response for T-cell receptor (TCR) mutants in patients repeatedly treated with 131I for thyroid cancer
    Stanislav Vershenya
    Klinik und Poliklinik für Nuklearmedizin der Universität, Wurzburg, Josef Schneider Street 2, D 97080 Wuerzburg, Germany
    Mutat Res 548:27-33. 2004
    ..7 x 10(-7). After the maximum TCR-Mf declines exponentially. The half-life of TCR mutants was found to be 3.2 years. On the basis of these data, a calibration curve for the use of TCR-Mf as a biological dosimeter is given...
  41. ncbi request reprint A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
    ..Levothyroxine (L-T4) withdrawal for thyroglobulin measurement and whole body scanning increases these tests' sensitivities but causes hypothyroidism. Recombinant human TSH (rhTSH) enables testing without L-T4 withdrawal...
  42. ncbi request reprint Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
    Martin Schlumberger
    Institut Gustave Roussy, Villejuif, France
    Eur J Endocrinol 150:105-12. 2004
    ..We sought to develop an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies...
  43. ncbi request reprint [Subclinical thyroid disease]
    Harald Schicha
    Nuklearmedizin 43:69-71. 2004
  44. ncbi request reprint Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin
    Sarah Kaufmann
    Institut für Experimentelle Endokrinologie, Charite, Universtätsmedizin Berlin, 10117 Berlin, Germany
    Endocr Regul 38:41-9. 2004
    ..As a possible diagnostic alternative, we tested a real time RT-PCR protocol to determine Tg mRNA levels in peripheral blood...
  45. ncbi request reprint Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH
    Michael Lassmann
    J Nucl Med 46:900-1; author reply 901. 2005
  46. pmc Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus
    Yuri E Demidchik
    Department for Oncology, Belarusian State Medical University, Minsk, Belarus
    Ann Surg 243:525-32. 2006
    ..A retrospective study was designed to evaluate the results of surgical treatment and follow-up data in thyroid cancer patients less than 15 years old at the time of surgery...
  47. ncbi request reprint Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer
    Michael Lassmann
    J Nucl Med 46:899. 2005
  48. ncbi request reprint [Blockade of iodine in thyroid cancer in known cases. Principles, effectiveness and actual cases]
    Christoph Reiners
    Nuklearmedizin 45:97-100. 2006
  49. ncbi request reprint Cancer consequences of the Chernobyl accident: 20 years on
    Elisabeth Cardis
    International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France
    J Radiol Prot 26:127-40. 2006
    ....
  50. ncbi request reprint Evaluation of the reticulocyte micronucleus assay in patients treated with radioiodine for thyroid cancer
    Jan Grawe
    Rudbeck Laboratory, University of Uppsala, Dag Hammarskjölds väg 20, 75185 Uppsala, Sweden
    Mutat Res 583:12-25. 2005
    ..Striking similarities in the kinetic and in the yield of MN-induction were found between these two species. This lends support for the use of the mouse as a model for the MN-induction in humans...
  51. ncbi request reprint Childhood thyroid cancers and radioactive iodine therapy: necessity of precautious radiation health risk management
    Atsushi Kumagai
    Department of Molecular Medicine, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
    Endocr J 54:839-47. 2007
    ..Period of latency of second primary cancers may be very long. Therefore patients treated with high activities of radioactive iodine, especially children cases, should be carefully followed up during their whole lifespan...
  52. pmc Expanding indications for recombinant human TSH in thyroid cancer
    Bryan R Haugen
    Thyroid 18:687-94. 2008
  53. ncbi request reprint Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US
    Andrej Lyshchik
    Laboratory of Thyroidology, Clinical Research Institute for Radiation Medicine and Endocrinology, Minsk, Belarus
    Radiology 235:604-13. 2005
    ..To prospectively analyze the accuracy of various diagnostic criteria for cancer in solid thyroid nodules in children on the basis of gray-scale and power Doppler ultrasonographic (US) findings...
  54. ncbi request reprint [The LISA trial-a- randomized, double-blind, placebo-controlled four-arm study of 1,000 patients with nodular goiter in Germany. Study Design and first results of feasibility]
    Martin Grussendorf
    Endokrinologie und Diabetologie im Zentrum, Stuttgart
    Med Klin (Munich) 100:542-6. 2005
    ..levothyroxine [T] vs. iodine [I] vs. levothyroxine + iodine [TI]) multicenter study was started in Germany (LISA study)...
  55. ncbi request reprint Three-dimensional ultrasonography for volume measurement of thyroid nodules in children
    Andrej Lyshchik
    Laboratory of Thyroidology, Clinical Research Institute for Radiation Medicine and Endocrinology, Minsk, Belarus
    J Ultrasound Med 23:247-54. 2004
    ....
  56. ncbi request reprint Technical evaluation of a new immunoradiometric and a new immunoluminometric assay for thyroglobulin
    Nils G Morgenthaler
    B R A H M S Biotechnology Centre Hennigsdorf Berlin, D 16761 Hennigsdorf bei Berlin, Germany
    Clin Chem 48:1077-83. 2002
    ..After removal of differentiated thyroid carcinoma (DTC), serum thyroglobulin (Tg) can indicate persistent or recurrent disease. We describe two novel two-step assays designed to measure low Tg concentrations...